4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000052
Chief Financial Officer sold 672 shares at $32.57 ($21,887)
- Chief Financial Officer acquired 2,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jones Cecilia · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,000 | 15,512 | D | ||
| 2024-03-05 | Sale : show line 2 in the form 10b5-1 | −672 | $32.57 | $21,887 | 14,840 | D |
| Open-market sales · 672 sh · avg $32.57 · $21,887 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-01 | Grant or award : show line 3 in the form 10b5-1 Restricted stock units | +17,000 | 17,000 | D |
| 2024-03-01 | Grant or award : show line 4 in the form 10b5-1 Stock options (right to buy) | +60,000 | 60,000 | D |
| 2024-03-01 | Exercise or conversion : show line 5 in the form 10b5-1 Restricted stock units | −2,000 | 4,000 | D |
Loading xslF345X05/wk-form4_1709673462.xml…